Factors such as the development of technologically advanced defibrillators, expanding aging population pool with high risk of chronic diseases, increasing incidences of cardiovascular diseases across the globe and growing focus of key market players toward public access defibrillation are fuelling the growth of the global defibrillators market. The market may reach USD 14.21 billion from USD 10.01 billion over 2016-2021. It is estimated to grow at a CAGR of 7.3%. Geographically, North America would lead the global market in 2016, followed by Europe. The Asia Pacific defibrillators market is poised to witness the highest growth rate during the forecast period 2016-2021 owing to a number of factors such as improving healthcare infrastructure, favorable government initiatives and growing focus of market players on the Asia Pacific defibrillators market. The market is highly consolidated as the global players, including Medtronic, St. Jude Medical, Boston Scientific, Biotronik, Philips and ZOLL Medical, together held a share of approximately 90% of the overall defibrillators market in 2015.
International defibrillators market forecast to grow at CAGR of 7.3% by 2021
GHI Analysis1 min read
GHI Analysis
The leading source of MedTech market intelligence in Latin America. Verified data and competitor insights across the key markets in the region. At GHI, we turn hospital data into strategic actions. Our insights help healthcare companies expand by providing accurate, up-to-date information on hospital infrastructure in LATAM and Asia.
Related Posts
News
Colombia prohibits surgical aesthetic procedures for under-18 children
Colombia prohibits surgical aesthetic procedures for under-18 children
President Juan Manuel Santos of Colombia has sanctioned a new bill which prohibits surgical aesthetic…
GHI Analysisagosto 2, 2016
Análise de GHI
Healthcare Update for Colombia — August 2021
Healthcare Update for Colombia — August 2021
Explore this series of reports that capture the latest data about Colombian hospitals
GHI Analysisagosto 27, 2021
News
Boston Scientific to acquire endoscopic ultrasound company Xlumena
Boston Scientific to acquire endoscopic ultrasound company Xlumena
Boston Scientific has inked an agreement to acquire Xlumena, which, develops, manufactures and sells minimally…
GHI Analysisabril 7, 2015